Displaying drugs 7101 - 7125 of 9780 in total
Inhibitor Idd 384
Experimental
LY-2608204
LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Investigational
4SC-202
4SC-202 has been used in trials studying the treatment of Advanced Hematologic Malignancies.
Investigational
Succinylsulfathiazole
Experimental
Cysteinamide
Experimental
N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE
Experimental
N-Acetyl-Serine
Experimental
Oseltamivir acid
Experimental
XV638
Experimental
FR-234938
Experimental
Gallichrome
Experimental
INHIBITOR Q8467 OF DUPONT MERCK
Experimental
Sofalcone
Sofalcone is a mucosal protective agent that has been reported to inhibit growth of Helicobacter pylori. on adherence, production of vacuolating toxin (VT), and induction of interleukin-8 (IL-8) secretion by H. pylori.
Investigational
2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid
Metabolic product of biphenyl; from Pseudomonas putida.
Experimental
Amedalin
Amedalin is a selective norepinephrine reuptake inhibitor developed in the 1970s. It has no significant effect on reuptake of serotonin and dopamine and no antihistamine or anticholinergic properties. This drug was never marketed.
Experimental
HT-0712
BLX-028914 has been used in trials studying the treatment and basic science of Allergic Rhinitis and Age-Associated Memory Impairment (AAMI).
Investigational
ZD-6126
ZD6126 has been used in trials studying the treatment of Kidney Neoplasms, Colorectal Neoplasms, Metastases, Neoplasm, and Carcinoma, Renal Cell.
Investigational
Ricolinostat
Ricolinostat is under investigation for the treatment of Breast Carcinoma and Metastatic Breast Cancer.
Investigational
Displaying drugs 7101 - 7125 of 9780 in total